Home > > > Report Detail

Global Exosomes Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 12-Feb-2020
No. of pages: 102

Market Overview

The global Exosomes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.2% in the forecast period of 2020 to 2025 and will expected to reach USD 411 million by 2025, from USD 278.6 million in 2019.

The Exosomes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Exosomes market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Exosomes market has been segmented into:

- Non-coding RNAs

- Lipids

- mRNA

- DNA fragments

- Proteins /peptides

By Application, Exosomes has been segmented into:

- Cancer

- Infectious diseases

- Neurodegenerative diseases

- Cardiovascular diseases

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Exosomes market presented in the report. This section sheds light on the sales growth of different regional and country-level Exosomes markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Exosomes market.

The report offers in-depth assessment of the growth and other aspects of the Exosomes market in important countries (regions), including:

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

- South America (Brazil, Argentina, Colombia)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Exosomes Market Share Analysis

Exosomes competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Exosomes sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Exosomes sales, revenue and market share for each player covered in this report.

The major players covered in Exosomes are:

Fujifilm

Miltenyi Biotec

Illumina

Thermo Fisher Scientific

Malvern Instruments

Danaher

Lonza

Takara Bio

Qiagen

MBL International

Global Exosomes Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Exosomes Market Overview
1.1 Product Overview and Scope of Exosomes
1.2 Classification of Exosomes by Type
1.2.1 Global Exosomes Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Exosomes Revenue Market Share by Type in 2019
1.2.3 Non-coding RNAs
1.2.4 Lipids
1.2.5 mRNA
1.2.6 DNA fragments
1.2.7 Proteins /peptides
1.3 Global Exosomes Market by Application
1.3.1 Overview: Global Exosomes Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Infectious diseases
1.3.4 Neurodegenerative diseases
1.3.5 Cardiovascular diseases
1.4 Global Exosomes Market by Regions
1.4.1 Global Exosomes Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Exosomes (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Exosomes Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Exosomes Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exosomes Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Exosomes Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exosomes Status and Prospect (2015-2025)
2 Company Profiles
2.1 Fujifilm
2.1.1 Fujifilm Details
2.1.2 Fujifilm Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Fujifilm SWOT Analysis
2.1.4 Fujifilm Product and Services
2.1.5 Fujifilm Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.2 Miltenyi Biotec
2.2.1 Miltenyi Biotec Details
2.2.2 Miltenyi Biotec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Miltenyi Biotec SWOT Analysis
2.2.4 Miltenyi Biotec Product and Services
2.2.5 Miltenyi Biotec Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Illumina SWOT Analysis
2.3.4 Illumina Product and Services
2.3.5 Illumina Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.5 Malvern Instruments
2.5.1 Malvern Instruments Details
2.5.2 Malvern Instruments Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Malvern Instruments SWOT Analysis
2.5.4 Malvern Instruments Product and Services
2.5.5 Malvern Instruments Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Danaher SWOT Analysis
2.6.4 Danaher Product and Services
2.6.5 Danaher Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lonza SWOT Analysis
2.7.4 Lonza Product and Services
2.7.5 Lonza Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.8 Takara Bio
2.8.1 Takara Bio Details
2.8.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Takara Bio SWOT Analysis
2.8.4 Takara Bio Product and Services
2.8.5 Takara Bio Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.9 Qiagen
2.9.1 Qiagen Details
2.9.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Qiagen SWOT Analysis
2.9.4 Qiagen Product and Services
2.9.5 Qiagen Exosomes Revenue, Gross Margin and Market Share (2018-2019)
2.10 MBL International
2.10.1 MBL International Details
2.10.2 MBL International Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 MBL International SWOT Analysis
2.10.4 MBL International Product and Services
2.10.5 MBL International Exosomes Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Exosomes Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Exosomes Players Market Share
3.2.2 Top 10 Exosomes Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Exosomes Revenue and Market Share by Regions
4.2 North America Exosomes Revenue and Growth Rate (2015-2020)
4.3 Europe Exosomes Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Exosomes Revenue and Growth Rate (2015-2020)
4.5 South America Exosomes Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Exosomes Revenue and Growth Rate (2015-2020)
5 North America Exosomes Revenue by Countries
5.1 North America Exosomes Revenue by Countries (2015-2020)
5.2 USA Exosomes Revenue and Growth Rate (2015-2020)
5.3 Canada Exosomes Revenue and Growth Rate (2015-2020)
5.4 Mexico Exosomes Revenue and Growth Rate (2015-2020)
6 Europe Exosomes Revenue by Countries
6.1 Europe Exosomes Revenue by Countries (2015-2020)
6.2 Germany Exosomes Revenue and Growth Rate (2015-2020)
6.3 UK Exosomes Revenue and Growth Rate (2015-2020)
6.4 France Exosomes Revenue and Growth Rate (2015-2020)
6.5 Russia Exosomes Revenue and Growth Rate (2015-2020)
6.6 Italy Exosomes Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Exosomes Revenue by Countries
7.1 Asia-Pacific Exosomes Revenue by Countries (2015-2020)
7.2 China Exosomes Revenue and Growth Rate (2015-2020)
7.3 Japan Exosomes Revenue and Growth Rate (2015-2020)
7.4 Korea Exosomes Revenue and Growth Rate (2015-2020)
7.5 India Exosomes Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Exosomes Revenue and Growth Rate (2015-2020)
8 South America Exosomes Revenue by Countries
8.1 South America Exosomes Revenue by Countries (2015-2020)
8.2 Brazil Exosomes Revenue and Growth Rate (2015-2020)
8.3 Argentina Exosomes Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Exosomes by Countries
9.1 Middle East & Africa Exosomes Revenue by Countries (2015-2020)
9.2 Saudi Arabia Exosomes Revenue and Growth Rate (2015-2020)
9.3 UAE Exosomes Revenue and Growth Rate (2015-2020)
9.4 Egypt Exosomes Revenue and Growth Rate (2015-2020)
9.5 South Africa Exosomes Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Exosomes Revenue and Market Share by Type (2015-2020)
10.2 Global Exosomes Market Forecast by Type (2019-2024)
10.3 Non-coding RNAs Revenue Growth Rate (2015-2025)
10.4 Lipids Revenue Growth Rate (2015-2025)
10.5 mRNA Revenue Growth Rate (2015-2025)
10.6 DNA fragments Revenue Growth Rate (2015-2025)
10.7 Proteins /peptides Revenue Growth Rate (2015-2025)
11 Global Exosomes Market Segment by Application
11.1 Global Exosomes Revenue Market Share by Application (2015-2020)
11.2 Exosomes Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Infectious diseases Revenue Growth (2015-2020)
11.5 Neurodegenerative diseases Revenue Growth (2015-2020)
11.6 Cardiovascular diseases Revenue Growth (2015-2020)
12 Global Exosomes Market Size Forecast (2021-2025)
12.1 Global Exosomes Market Size Forecast (2021-2025)
12.2 Global Exosomes Market Forecast by Regions (2021-2025)
12.3 North America Exosomes Revenue Market Forecast (2021-2025)
12.4 Europe Exosomes Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Exosomes Revenue Market Forecast (2021-2025)
12.6 South America Exosomes Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Exosomes Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Exosomes Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Exosomes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Exosomes Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Exosomes Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Fujifilm Corporate Information, Location and Competitors
Table 6. Fujifilm Exosomes Major Business
Table 7. Fujifilm Exosomes Total Revenue (USD Million) (2017-2018)
Table 8. Fujifilm SWOT Analysis
Table 9. Fujifilm Exosomes Product and Solutions
Table 10. Fujifilm Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Miltenyi Biotec Corporate Information, Location and Competitors
Table 12. Miltenyi Biotec Exosomes Major Business
Table 13. Miltenyi Biotec Exosomes Total Revenue (USD Million) (2018-2019)
Table 14. Miltenyi Biotec SWOT Analysis
Table 15. Miltenyi Biotec Exosomes Product and Solutions
Table 16. Miltenyi Biotec Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Illumina Corporate Information, Location and Competitors
Table 18. Illumina Exosomes Major Business
Table 19. Illumina Exosomes Total Revenue (USD Million) (2017-2018)
Table 20. Illumina SWOT Analysis
Table 21. Illumina Exosomes Product and Solutions
Table 22. Illumina Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Exosomes Major Business
Table 25. Thermo Fisher Scientific Exosomes Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific SWOT Analysis
Table 27. Thermo Fisher Scientific Exosomes Product and Solutions
Table 28. Thermo Fisher Scientific Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Malvern Instruments Corporate Information, Location and Competitors
Table 30. Malvern Instruments Exosomes Major Business
Table 31. Malvern Instruments Exosomes Total Revenue (USD Million) (2017-2018)
Table 32. Malvern Instruments SWOT Analysis
Table 33. Malvern Instruments Exosomes Product and Solutions
Table 34. Malvern Instruments Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Danaher Corporate Information, Location and Competitors
Table 36. Danaher Exosomes Major Business
Table 37. Danaher Exosomes Total Revenue (USD Million) (2017-2018)
Table 38. Danaher SWOT Analysis
Table 39. Danaher Exosomes Product and Solutions
Table 40. Danaher Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Lonza Corporate Information, Location and Competitors
Table 42. Lonza Exosomes Major Business
Table 43. Lonza Exosomes Total Revenue (USD Million) (2017-2018)
Table 44. Lonza SWOT Analysis
Table 45. Lonza Exosomes Product and Solutions
Table 46. Lonza Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Takara Bio Corporate Information, Location and Competitors
Table 48. Takara Bio Exosomes Major Business
Table 49. Takara Bio Exosomes Total Revenue (USD Million) (2017-2018)
Table 50. Takara Bio SWOT Analysis
Table 51. Takara Bio Exosomes Product and Solutions
Table 52. Takara Bio Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Qiagen Corporate Information, Location and Competitors
Table 54. Qiagen Exosomes Major Business
Table 55. Qiagen Exosomes Total Revenue (USD Million) (2017-2018)
Table 56. Qiagen SWOT Analysis
Table 57. Qiagen Exosomes Product and Solutions
Table 58. Qiagen Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. MBL International Corporate Information, Location and Competitors
Table 60. MBL International Exosomes Major Business
Table 61. MBL International Exosomes Total Revenue (USD Million) (2017-2018)
Table 62. MBL International SWOT Analysis
Table 63. MBL International Exosomes Product and Solutions
Table 64. MBL International Exosomes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Exosomes Revenue (Million USD) by Players (2015-2020)
Table 66. Global Exosomes Revenue Share by Players (2015-2020)
Table 67. Global Exosomes Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Exosomes Revenue Market Share by Regions (2015-2020)
Table 69. North America Exosomes Revenue by Countries (2015-2020)
Table 70. North America Exosomes Revenue Market Share by Countries (2015-2020)
Table 71. Europe Exosomes Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Exosomes Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Exosomes Revenue by Countries (2015-2020)
Table 74. South America Exosomes Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Exosomes Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Exosomes Revenue Market Share by Countries (2015-2020)
Table 77. Global Exosomes Revenue (Million USD) by Type (2015-2020)
Table 78. Global Exosomes Revenue Share by Type (2015-2020)
Table 79. Global Exosomes Revenue Forecast by Type (2021-2025)
Table 80. Global Exosomes Revenue by Application (2015-2020)
Table 81. Global Exosomes Revenue Share by Application (2015-2020)
Table 82. Global Exosomes Revenue Forecast by Application (2021-2025)
Table 83. Global Exosomes Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Exosomes Picture
Figure 2. Global Exosomes Revenue Market Share by Type in 2019
Figure 3. Non-coding RNAs Picture
Figure 4. Lipids Picture
Figure 5. mRNA Picture
Figure 6. DNA fragments Picture
Figure 7. Proteins /peptides Picture
Figure 8. Exosomes Revenue Market Share by Application in 2019
Figure 9. Cancer Picture
Figure 10. Infectious diseases Picture
Figure 11. Neurodegenerative diseases Picture
Figure 12. Cardiovascular diseases Picture
Figure 13. Global Exosomes Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Exosomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Exosomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Exosomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Exosomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Exosomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Exosomes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Exosomes Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Exosomes Revenue Market Share in 2019
Figure 22. Global Top 10 Players Exosomes Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Exosomes Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Exosomes Revenue Market Share by Regions (2015-2020)
Figure 26. Global Exosomes Revenue Market Share by Regions in 2018
Figure 27. North America Exosomes Revenue and Growth Rate (2015-2020)
Figure 28. Europe Exosomes Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Exosomes Revenue and Growth Rate (2015-2020)
Figure 30. South America Exosomes Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Exosomes Revenue and Growth Rate (2015-2020)
Figure 32. North America Exosomes Revenue Market Share by Countries (2015-2020)
Figure 33. North America Exosomes Revenue Market Share by Countries in 2019
Figure 34. USA Exosomes Revenue and Growth Rate (2015-2020)
Figure 35. Canada Exosomes Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Exosomes Revenue and Growth Rate (2015-2020)
Figure 37. Europe Exosomes Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Exosomes Revenue Market Share by Countries in 2019
Figure 39. Germany Exosomes Revenue and Growth Rate (2015-2020)
Figure 40. UK Exosomes Revenue and Growth Rate (2015-2020)
Figure 41. France Exosomes Revenue and Growth Rate (2015-2020)
Figure 42. Russia Exosomes Revenue and Growth Rate (2015-2020)
Figure 43. Italy Exosomes Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Exosomes Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Exosomes Revenue Market Share by Countries in 2019
Figure 46. China Exosomes Revenue and Growth Rate (2015-2020)
Figure 47. Japan Exosomes Revenue and Growth Rate (2015-2020)
Figure 48. Korea Exosomes Revenue and Growth Rate (2015-2020)
Figure 49. India Exosomes Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Exosomes Revenue and Growth Rate (2015-2020)
Figure 51. South America Exosomes Revenue Market Share by Countries (2015-2020)
Figure 52. South America Exosomes Revenue Market Share by Countries in 2019
Figure 53. Brazil Exosomes Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Exosomes Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Exosomes Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Exosomes Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Exosomes Revenue and Growth Rate (2015-2020)
Figure 58. UAE Exosomes Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Exosomes Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Exosomes Revenue and Growth Rate (2015-2020)
Figure 61. Global Exosomes Revenue Share by Type (2015-2020)
Figure 62. Global Exosomes Revenue Share by Type in 2019
Figure 63. Global Exosomes Market Share Forecast by Type (2021-2025)
Figure 64. Global Non-coding RNAs Revenue Growth Rate (2015-2020)
Figure 65. Global Lipids Revenue Growth Rate (2015-2020)
Figure 66. Global mRNA Revenue Growth Rate (2015-2020)
Figure 67. Global DNA fragments Revenue Growth Rate (2015-2020)
Figure 68. Global Proteins /peptides Revenue Growth Rate (2015-2020)
Figure 69. Global Exosomes Revenue Share by Application (2015-2020)
Figure 70. Global Exosomes Revenue Share by Application in 2019
Figure 71. Global Exosomes Market Share Forecast by Application (2021-2025)
Figure 72. Global Cancer Revenue Growth Rate (2015-2020)
Figure 73. Global Infectious diseases Revenue Growth Rate (2015-2020)
Figure 74. Global Neurodegenerative diseases Revenue Growth Rate (2015-2020)
Figure 75. Global Cardiovascular diseases Revenue Growth Rate (2015-2020)
Figure 76. Global Exosomes Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Exosomes Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Exosomes Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Exosomes Revenue Market Forecast (2021-2025)
Figure 80. Europe Exosomes Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Exosomes Revenue Market Forecast (2021-2025)
Figure 82. South America Exosomes Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Exosomes Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs